Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the safety and tolerability of three dose strengths of the study drug in subjects with post cataract extraction macular edema.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00135655
Study type Interventional
Source Merck Sharp & Dohme Corp.
Contact
Status Withdrawn
Phase Phase 2
Start date August 2005

See also
  Status Clinical Trial Phase
Completed NCT03559491 - Dexamethasone Intravitreal Implant in Retinal Vein Occlusion
Completed NCT00105027 - The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study Phase 3
Completed NCT01546402 - Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema Phase 4
Completed NCT00106132 - Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage Phase 3
Completed NCT04472039 - Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling
Completed NCT00335439 - Effect of Prophylactic Ketorolac on CME After Cataract Surgery N/A
Terminated NCT02665689 - Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab Phase 4
Completed NCT01698749 - Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema N/A
Completed NCT00000115 - Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema Phase 2
Completed NCT00001738 - Vascular Endothelial Growth Factor (VEGF) in Uveitis N/A